Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
18%
Ph not_applicable
6
55%
Ph phase_3
2
18%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(1)
Other(1)

Detailed Status

Completed9
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (20.0%)
Phase 42 (20.0%)
N/A6 (60.0%)

Trials by Status

completed982%
withdrawn19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11